Psoriasis: open trials in Portugal

• NCT03671148

  A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(ies) (KEEPsAKE 2)

  Trial Treatment · Phase 3 · AbbVie Deutschland GmbH & Co. KG

  Instituto Portugues de Reumatologia, Lisbon · Centro Hospitalar Universitario De Lisboa Norte E.P.E., Lisbon · Unidade Local De Saude Do Alto Minho E.P.E., Ponte De Lima

  Registry updated 2026-11-03

• NCT06663332

  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  CCAB Centro Clinico Academico Braga Associacao, Braga · Unidade Local de Saude de Sao Joao E.P.E., Porto

  Registry updated 2026-11-03

• NCT04638647

  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  Trial Treatment · Phase 4 · Novartis Pharma AG

  Unidade Local De Saude De Santa Maria E.P.E., Lisbon

  Registry updated 2026-09-25

• NCT06846541

  An Extension Study to Evaluate Safety, Efficacy, and Durability of Response to ESK-001 for Moderate to Severe Plaque Psoriasis (ONWARD3)

  Trial Treatment · Phase 3 · Alumis Inc.

  Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes · Hospital Cuf Descobertas S.A., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto

  Registry updated 2026-09-16

• NCT07772544

  Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study

  Trial Treatment · Sociedade Portuguesa de Reumatologia

  Unidade Local de Saúde de Aveiro, Serviço de Reumatologia, Hospital Infante Dom Pedro, Aveiro · Unidade Local de Saúde de São José, Serviço de Reumatologia, Hospital Santo António dos Capuchos, Lisbon · Unidade Local de Saúde de São João, Serviço de Reumatologia, Hospital São João, Porto

  Registry updated 2026-09-16

• NCT07286058

  A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Psoriatic Arthritis With or Without Prior Biologic DMARD Exposure

  Trial Treatment · Phase 3 · Takeda Development Center Americas Inc.

  Unidade Local De Saude De Almada-Seixal E.P.E., Almada · Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Instituto Portugues de Reumatologia, Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude Do Alto Minho E.P.E., Ponte De Lima · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia

  Registry updated 2026-07-22

• NCT04359394

  International Rare And Severe Psoriasis Expert Network

  Research · University Hospital, Basel, Switzerland

  Universitário do Porto, Porto

  Registry updated 2024-05-09

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error